#DOW JONES TODAY NOW DRIVER#

Even though Windows isn't going to be a significant growth driver moving forward, this segment generates exceptionally high margins and bountiful cash flow that Microsoft is using to invest in the cloud and artificial intelligence (AI), among other initiatives. While this is down from a 91% share in January 2013, it's still globally dominant. Minimal turnover at the top ensures that strategic visions are being implemented and closely monitored.įor example, the company's Windows operating system (OS) held a little over 76% of worldwide desktop OS share, as of June 2022.

In Johnson & Johnson's 137-year history, the company has had just eight CEOs. As the domestic and global population ages, demand for medical devices is expected to grow.Īside from its revenue mix, J&J benefits from vision continuity. It also has its industry-leading medical technologies segment to fall back on. That's why it continues to aggressively reinvest in internal drug development, forge collaborations, and make the occasional acquisition.

However, Johnson & Johnson is prepared for the loss of exclusivity on its therapies over time. If there's a downside to this strategy, it's that brand-name drugs have a finite period of sales exclusivity. For more than a decade, J&J has been shifting more of its total sales to high-margin, brand-name pharmaceuticals. For starters, the company's revenue mix is moving the needle in the right direction. On a company-specific basis, there are a couple of things that make Johnson & Johnson special.

Dow jones today now